Global Paediatric Influenza Treatment Market Insights, Forecast to 2030

TABLE OF CONTENTS

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Paediatric Influenza Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
  • 1.2.2 Oseltamivir
  • 1.2.3 Zanamivir
  • 1.2.4 Amantadine
  • 1.2.5 Rimantadine
  • 1.2.6 Other
• 1.3 Market by Application
  • 1.3.1 Global Paediatric Influenza Treatment Market Share by Application: 2019 VS 2023 VS 2030
  • 1.3.2 Hospital
  • 1.3.3 Retail Pharmacy
  • 1.3.4 Other
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Paediatric Influenza Treatment Market Perspective (2019-2030)
• 2.2 Global Paediatric Influenza Treatment Growth Trends by Region
  • 2.2.1 Global Paediatric Influenza Treatment Market Size by Region: 2019 VS 2023 VS 2030
  • 2.2.2 Paediatric Influenza Treatment Historic Market Size by Region (2019-2024)
  • 2.2.3 Paediatric Influenza Treatment Forecasted Market Size by Region (2025-2030)
• 2.3 Paediatric Influenza Treatment Market Dynamics
  • 2.3.1 Paediatric Influenza Treatment Industry Trends
  • 2.3.2 Paediatric Influenza Treatment Market Drivers
  • 2.3.3 Paediatric Influenza Treatment Market Challenges
  • 2.3.4 Paediatric Influenza Treatment Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Revenue Paediatric Influenza Treatment by Players
  • 3.1.1 Global Paediatric Influenza Treatment Revenue by Players (2019-2024)
  • 3.1.2 Global Paediatric Influenza Treatment Revenue Market Share by Players (2019-2024)
• 3.2 Global Paediatric Influenza Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 3.3 Global Key Players of Paediatric Influenza Treatment, Ranking by Revenue, 2022 VS 2023 VS 2024
• 3.4 Global Paediatric Influenza Treatment Market Concentration Ratio
  • 3.4.1 Global Paediatric Influenza Treatment Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Paediatric Influenza Treatment Revenue in 2023
• 3.5 Global Key Players of Paediatric Influenza Treatment Head office and Area Served
• 3.6 Global Key Players of Paediatric Influenza Treatment, Product and Application
• 3.7 Global Key Players of Paediatric Influenza Treatment, Date of Enter into This Industry
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Paediatric Influenza Treatment Breakdown Data by Type

• 4.1 Global Paediatric Influenza Treatment Historic Market Size by Type (2019-2024)
• 4.2 Global Paediatric Influenza Treatment Forecasted Market Size by Type (2025-2030)

5 Paediatric Influenza Treatment Breakdown Data by Application

• 5.1 Global Paediatric Influenza Treatment Historic Market Size by Application (2019-2024)
• 5.2 Global Paediatric Influenza Treatment Forecasted Market Size by Application (2025-2030)

6 North America

• 6.1 North America Paediatric Influenza Treatment Market Size (2019-2030)
• 6.2 North America Paediatric Influenza Treatment Market Size by Type
  • 6.2.1 North America Paediatric Influenza Treatment Market Size by Type (2019-2024)
  • 6.2.2 North America Paediatric Influenza Treatment Market Size by Type (2025-2030)
  • 6.2.3 North America Paediatric Influenza Treatment Market Share by Type (2019-2030)
• 6.3 North America Paediatric Influenza Treatment Market Size by Application
  • 6.3.1 North America Paediatric Influenza Treatment Market Size by Application (2019-2024)
  • 6.3.2 North America Paediatric Influenza Treatment Market Size by Application (2025-2030)
  • 6.3.3 North America Paediatric Influenza Treatment Market Share by Application (2019-2030)
• 6.4 North America Paediatric Influenza Treatment Market Size by Country
  • 6.4.1 North America Paediatric Influenza Treatment Market Size by Country: 2019 VS 2023 VS 2030
  • 6.4.2 North America Paediatric Influenza Treatment Market Size by Country (2019-2024)
  • 6.4.3 North America Paediatric Influenza Treatment Market Share by Country (2025-2030)
  • 6.4.4 United States
  • 6.4.5 Canada

7 Europe

• 7.1 Europe Paediatric Influenza Treatment Market Size (2019-2030)
• 7.2 Europe Paediatric Influenza Treatment Market Size by Type
  • 7.2.1 Europe Paediatric Influenza Treatment Market Size by Type (2019-2024)
  • 7.2.2 Europe Paediatric Influenza Treatment Market Size by Type (2025-2030)
  • 7.2.3 Europe Paediatric Influenza Treatment Market Share by Type (2019-2030)
• 7.3 Europe Paediatric Influenza Treatment Market Size by Application
  • 7.3.1 Europe Paediatric Influenza Treatment Market Size by Application (2019-2024)
  • 7.3.2 Europe Paediatric Influenza Treatment Market Size by Application (2025-2030)
  • 7.3.3 Europe Paediatric Influenza Treatment Market Share by Application (2019-2030)
• 7.4 Europe Paediatric Influenza Treatment Market Size by Country
  • 7.4.1 Europe Paediatric Influenza Treatment Market Size by Country: 2019 VS 2023 VS 2030
  • 7.4.2 Europe Paediatric Influenza Treatment Market Size by Country (2019-2024)
  • 7.4.3 Europe Paediatric Influenza Treatment Market Size by Country (2025-2030)
  • 7.4.4 Germany
  • 7.4.5 France
  • 7.4.6 U.K.
  • 7.4.7 Italy
  • 7.4.8 Russia
  • 7.4.9 Nordic Countries

8 China

• 8.1 China Paediatric Influenza Treatment Market Size (2019-2030)
• 8.2 China Paediatric Influenza Treatment Market Size by Type
  • 8.2.1 China Paediatric Influenza Treatment Market Size by Type (2019-2024)
  • 8.2.2 China Paediatric Influenza Treatment Market Size by Type (2025-2030)
  • 8.2.3 China Paediatric Influenza Treatment Market Share by Type (2019-2030)
• 8.3 China Paediatric Influenza Treatment Market Size by Application
  • 8.3.1 China Paediatric Influenza Treatment Market Size by Application (2019-2024)
  • 8.3.2 China Paediatric Influenza Treatment Market Size by Application (2025-2030)
  • 8.3.3 China Paediatric Influenza Treatment Market Share by Application (2019-2030)

9 Asia (excluding China)

• 9.1 Asia Paediatric Influenza Treatment Market Size (2019-2030)
• 9.2 Asia Paediatric Influenza Treatment Market Size by Type
  • 9.2.1 Asia Paediatric Influenza Treatment Market Size by Type (2019-2024)
  • 9.2.2 Asia Paediatric Influenza Treatment Market Size by Type (2025-2030)
  • 9.2.3 Asia Paediatric Influenza Treatment Market Share by Type (2019-2030)
• 9.3 Asia Paediatric Influenza Treatment Market Size by Application
  • 9.3.1 Asia Paediatric Influenza Treatment Market Size by Application (2019-2024)
  • 9.3.2 Asia Paediatric Influenza Treatment Market Size by Application (2025-2030)
  • 9.3.3 Asia Paediatric Influenza Treatment Market Share by Application (2019-2030)
• 9.4 Asia Paediatric Influenza Treatment Market Size by Region
  • 9.4.1 Asia Paediatric Influenza Treatment Market Size by Region: 2019 VS 2023 VS 2030
  • 9.4.2 Asia Paediatric Influenza Treatment Market Size by Region (2019-2024)
  • 9.4.3 Asia Paediatric Influenza Treatment Market Size by Region (2025-2030)
  • 9.4.4 Japan
  • 9.4.5 South Korea
  • 9.4.6 China Taiwan
  • 9.4.7 Southeast Asia
  • 9.4.8 India
  • 9.4.9 Australia

10 Middle East, Africa, and Latin America

• 10.1 Middle East, Africa, and Latin America Paediatric Influenza Treatment Market Size (2019-2030)
• 10.2 Middle East, Africa, and Latin America Paediatric Influenza Treatment Market Size by Type
  • 10.2.1 Middle East, Africa, and Latin America Paediatric Influenza Treatment Market Size by Type (2019-2024)
  • 10.2.2 Middle East, Africa, and Latin America Paediatric Influenza Treatment Market Size by Type (2025-2030)
  • 10.2.3 Middle East, Africa, and Latin America Paediatric Influenza Treatment Market Share by Type (2019-2030)
• 10.3 Middle East, Africa, and Latin America Paediatric Influenza Treatment Market Size by Application
  • 10.3.1 Middle East, Africa, and Latin America Paediatric Influenza Treatment Market Size by Application (2019-2024)
  • 10.3.2 Middle East, Africa, and Latin America Paediatric Influenza Treatment Market Size by Application (2025-2030)
  • 10.3.3 Middle East, Africa, and Latin America Paediatric Influenza Treatment Market Share by Application (2019-2030)
• 10.4 Middle East, Africa, and Latin America Paediatric Influenza Treatment Market Size by Country
  • 10.4.1 Middle East, Africa, and Latin America Paediatric Influenza Treatment Market Size by Country: 2019 VS 2023 VS 2030
  • 10.4.2 Middle East, Africa, and Latin America Paediatric Influenza Treatment Market Size by Country (2019-2024)
  • 10.4.3 Middle East, Africa, and Latin America Paediatric Influenza Treatment Market Size by Country (2025-2030)
  • 10.4.4 Brazil
  • 10.4.5 Mexico
  • 10.4.6 Turkey
  • 10.4.7 Saudi Arabia
  • 10.4.8 Israel
  • 10.4.9 GCC Countries

11 Key Players Profiles

• 11.1 GlaxoSmithKline
  • 11.1.1 GlaxoSmithKline Company Details
  • 11.1.2 GlaxoSmithKline Business Overview
  • 11.1.3 GlaxoSmithKline Paediatric Influenza Treatment Introduction
  • 11.1.4 GlaxoSmithKline Revenue in Paediatric Influenza Treatment Business (2019-2024)
  • 11.1.5 GlaxoSmithKline Recent Development
• 11.2 NATCO Pharma
  • 11.2.1 NATCO Pharma Company Details
  • 11.2.2 NATCO Pharma Business Overview
  • 11.2.3 NATCO Pharma Paediatric Influenza Treatment Introduction
  • 11.2.4 NATCO Pharma Revenue in Paediatric Influenza Treatment Business (2019-2024)
  • 11.2.5 NATCO Pharma Recent Development
• 11.3 NESHER PHARMS
  • 11.3.1 NESHER PHARMS Company Details
  • 11.3.2 NESHER PHARMS Business Overview
  • 11.3.3 NESHER PHARMS Paediatric Influenza Treatment Introduction
  • 11.3.4 NESHER PHARMS Revenue in Paediatric Influenza Treatment Business (2019-2024)
  • 11.3.5 NESHER PHARMS Recent Development
• 11.4 Roche
  • 11.4.1 Roche Company Details
  • 11.4.2 Roche Business Overview
  • 11.4.3 Roche Paediatric Influenza Treatment Introduction
  • 11.4.4 Roche Revenue in Paediatric Influenza Treatment Business (2019-2024)
  • 11.4.5 Roche Recent Development
• 11.5 Atabay Kimya Sanayi ve Ticaret
  • 11.5.1 Atabay Kimya Sanayi ve Ticaret Company Details
  • 11.5.2 Atabay Kimya Sanayi ve Ticaret Business Overview
  • 11.5.3 Atabay Kimya Sanayi ve Ticaret Paediatric Influenza Treatment Introduction
  • 11.5.4 Atabay Kimya Sanayi ve Ticaret Revenue in Paediatric Influenza Treatment Business (2019-2024)
  • 11.5.5 Atabay Kimya Sanayi ve Ticaret Recent Development
• 11.6 Cipla
  • 11.6.1 Cipla Company Details
  • 11.6.2 Cipla Business Overview
  • 11.6.3 Cipla Paediatric Influenza Treatment Introduction
  • 11.6.4 Cipla Revenue in Paediatric Influenza Treatment Business (2019-2024)
  • 11.6.5 Cipla Recent Development
• 11.7 Hetero Pharma
  • 11.7.1 Hetero Pharma Company Details
  • 11.7.2 Hetero Pharma Business Overview
  • 11.7.3 Hetero Pharma Paediatric Influenza Treatment Introduction
  • 11.7.4 Hetero Pharma Revenue in Paediatric Influenza Treatment Business (2019-2024)
  • 11.7.5 Hetero Pharma Recent Development
• 11.8 Teva Pharmaceutical
  • 11.8.1 Teva Pharmaceutical Company Details
  • 11.8.2 Teva Pharmaceutical Business Overview
  • 11.8.3 Teva Pharmaceutical Paediatric Influenza Treatment Introduction
  • 11.8.4 Teva Pharmaceutical Revenue in Paediatric Influenza Treatment Business (2019-2024)
  • 11.8.5 Teva Pharmaceutical Recent Development
• 11.9 Olainfarm
  • 11.9.1 Olainfarm Company Details
  • 11.9.2 Olainfarm Business Overview
  • 11.9.3 Olainfarm Paediatric Influenza Treatment Introduction
  • 11.9.4 Olainfarm Revenue in Paediatric Influenza Treatment Business (2019-2024)
  • 11.9.5 Olainfarm Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
    • 13.1.1.1 Research Programs/Design
    • 13.1.1.2 Market Size Estimation
    • 13.1.1.3 Market Breakdown and Data Triangulation
  • 13.1.2 Data Source
    • 13.1.2.1 Secondary Sources
    • 13.1.2.2 Primary Sources
• 13.2 Author Details
• 13.3 Disclaimer

List of Tables

Table 1. Global Paediatric Influenza Treatment Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Oseltamivir

Table 3. Key Players of Zanamivir

Table 4. Key Players of Amantadine

Table 5. Key Players of Rimantadine

Table 6. Key Players of Other

Table 7. Global Paediatric Influenza Treatment Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Paediatric Influenza Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 9. Global Paediatric Influenza Treatment Market Size by Region (2019-2024) & (US$ Million)

Table 10. Global Paediatric Influenza Treatment Market Share by Region (2019-2024)

Table 11. Global Paediatric Influenza Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 12. Global Paediatric Influenza Treatment Market Share by Region (2025-2030)

Table 13. Paediatric Influenza Treatment Market Trends

Table 14. Paediatric Influenza Treatment Market Drivers

Table 15. Paediatric Influenza Treatment Market Challenges

Table 16. Paediatric Influenza Treatment Market Restraints

Table 17. Global Paediatric Influenza Treatment Revenue by Players (2019-2024) & (US$ Million)

Table 18. Global Paediatric Influenza Treatment Market Share by Players (2019-2024)

Table 19. Global Top Paediatric Influenza Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Paediatric Influenza Treatment as of 2023)

Table 20. Global Paediatric Influenza Treatment Industry Ranking 2022 VS 2023

Table 21. Global 5 Largest Players Market Share by Paediatric Influenza Treatment Revenue (CR5 and HHI) & (2019-2024)

Table 22. Global Key Players of Paediatric Influenza Treatment, Headquarters and Area Served

Table 23. Global Key Players of Paediatric Influenza Treatment, Product and Application

Table 24. Global Key Players of Paediatric Influenza Treatment, Date of Enter into This Industry

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Paediatric Influenza Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 27. Global Paediatric Influenza Treatment Revenue Market Share by Type (2019-2024)

Table 28. Global Paediatric Influenza Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 29. Global Paediatric Influenza Treatment Revenue Market Share by Type (2025-2030)

Table 30. Global Paediatric Influenza Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 31. Global Paediatric Influenza Treatment Revenue Market Share by Application (2019-2024)

Table 32. Global Paediatric Influenza Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 33. Global Paediatric Influenza Treatment Revenue Market Share by Application (2025-2030)

Table 34. North America Paediatric Influenza Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 35. North America Paediatric Influenza Treatment Market Size by Type (2025-2030) & (US$ Million)

Table 36. North America Paediatric Influenza Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 37. North America Paediatric Influenza Treatment Market Size by Application (2025-2030) & (US$ Million)

Table 38. North America Paediatric Influenza Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 39. North America Paediatric Influenza Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 40. North America Paediatric Influenza Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 41. Europe Paediatric Influenza Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 42. Europe Paediatric Influenza Treatment Market Size by Type (2025-2030) & (US$ Million)

Table 43. Europe Paediatric Influenza Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 44. Europe Paediatric Influenza Treatment Market Size by Application (2025-2030) & (US$ Million)

Table 45. Europe Paediatric Influenza Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 46. Europe Paediatric Influenza Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 47. Europe Paediatric Influenza Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 48. China Paediatric Influenza Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 49. China Paediatric Influenza Treatment Market Size by Type (2025-2030) & (US$ Million)

Table 50. China Paediatric Influenza Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 51. China Paediatric Influenza Treatment Market Size by Application (2025-2030) & (US$ Million)

Table 52. Asia Paediatric Influenza Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 53. Asia Paediatric Influenza Treatment Market Size by Type (2025-2030) & (US$ Million)

Table 54. Asia Paediatric Influenza Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 55. Asia Paediatric Influenza Treatment Market Size by Application (2025-2030) & (US$ Million)

Table 56. Asia Paediatric Influenza Treatment Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 57. Asia Paediatric Influenza Treatment Market Size by Region (2019-2024) & (US$ Million)

Table 58. Asia Paediatric Influenza Treatment Market Size by Region (2025-2030) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Paediatric Influenza Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Paediatric Influenza Treatment Market Size by Type (2025-2030) & (US$ Million)

Table 61. Middle East, Africa, and Latin America Paediatric Influenza Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Paediatric Influenza Treatment Market Size by Application (2025-2030) & (US$ Million)

Table 63. Middle East, Africa, and Latin America Paediatric Influenza Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 64. Middle East, Africa, and Latin America Paediatric Influenza Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 65. Middle East, Africa, and Latin America Paediatric Influenza Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 66. GlaxoSmithKline Company Details

Table 67. GlaxoSmithKline Business Overview

Table 68. GlaxoSmithKline Paediatric Influenza Treatment Product

Table 69. GlaxoSmithKline Revenue in Paediatric Influenza Treatment Business (2019-2024) & (US$ Million)

Table 70. GlaxoSmithKline Recent Development

Table 71. NATCO Pharma Company Details

Table 72. NATCO Pharma Business Overview

Table 73. NATCO Pharma Paediatric Influenza Treatment Product

Table 74. NATCO Pharma Revenue in Paediatric Influenza Treatment Business (2019-2024) & (US$ Million)

Table 75. NATCO Pharma Recent Development

Table 76. NESHER PHARMS Company Details

Table 77. NESHER PHARMS Business Overview

Table 78. NESHER PHARMS Paediatric Influenza Treatment Product

Table 79. NESHER PHARMS Revenue in Paediatric Influenza Treatment Business (2019-2024) & (US$ Million)

Table 80. NESHER PHARMS Recent Development

Table 81. Roche Company Details

Table 82. Roche Business Overview

Table 83. Roche Paediatric Influenza Treatment Product

Table 84. Roche Revenue in Paediatric Influenza Treatment Business (2019-2024) & (US$ Million)

Table 85. Roche Recent Development

Table 86. Atabay Kimya Sanayi ve Ticaret Company Details

Table 87. Atabay Kimya Sanayi ve Ticaret Business Overview

Table 88. Atabay Kimya Sanayi ve Ticaret Paediatric Influenza Treatment Product

Table 89. Atabay Kimya Sanayi ve Ticaret Revenue in Paediatric Influenza Treatment Business (2019-2024) & (US$ Million)

Table 90. Atabay Kimya Sanayi ve Ticaret Recent Development

Table 91. Cipla Company Details

Table 92. Cipla Business Overview

Table 93. Cipla Paediatric Influenza Treatment Product

Table 94. Cipla Revenue in Paediatric Influenza Treatment Business (2019-2024) & (US$ Million)

Table 95. Cipla Recent Development

Table 96. Hetero Pharma Company Details

Table 97. Hetero Pharma Business Overview

Table 98. Hetero Pharma Paediatric Influenza Treatment Product

Table 99. Hetero Pharma Revenue in Paediatric Influenza Treatment Business (2019-2024) & (US$ Million)

Table 100. Hetero Pharma Recent Development

Table 101. Teva Pharmaceutical Company Details

Table 102. Teva Pharmaceutical Business Overview

Table 103. Teva Pharmaceutical Paediatric Influenza Treatment Product

Table 104. Teva Pharmaceutical Revenue in Paediatric Influenza Treatment Business (2019-2024) & (US$ Million)

Table 105. Teva Pharmaceutical Recent Development

Table 106. Olainfarm Company Details

Table 107. Olainfarm Business Overview

Table 108. Olainfarm Paediatric Influenza Treatment Product

Table 109. Olainfarm Revenue in Paediatric Influenza Treatment Business (2019-2024) & (US$ Million)

Table 110. Olainfarm Recent Development

Table 111. Research Programs/Design for This Report

Table 112. Key Data Information from Secondary Sources

Table 113. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Paediatric Influenza Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Paediatric Influenza Treatment Market Share by Type: 2023 VS 2030

Figure 3. Oseltamivir Features

Figure 4. Zanamivir Features

Figure 5. Amantadine Features

Figure 6. Rimantadine Features

Figure 7. Other Features

Figure 8. Global Paediatric Influenza Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 9. Global Paediatric Influenza Treatment Market Share by Application: 2023 VS 2030

Figure 10. Hospital Case Studies

Figure 11. Retail Pharmacy Case Studies

Figure 12. Other Case Studies

Figure 13. Paediatric Influenza Treatment Report Years Considered

Figure 14. Global Paediatric Influenza Treatment Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 15. Global Paediatric Influenza Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 16. Global Paediatric Influenza Treatment Market Share by Region: 2023 VS 2030

Figure 17. Global Paediatric Influenza Treatment Market Share by Players in 2023

Figure 18. Global Top Paediatric Influenza Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Paediatric Influenza Treatment as of 2023)

Figure 19. The Top 10 and 5 Players Market Share by Paediatric Influenza Treatment Revenue in 2023

Figure 20. North America Paediatric Influenza Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. North America Paediatric Influenza Treatment Market Share by Type (2019-2030)

Figure 22. North America Paediatric Influenza Treatment Market Share by Application (2019-2030)

Figure 23. North America Paediatric Influenza Treatment Market Share by Country (2019-2030)

Figure 24. United States Paediatric Influenza Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Canada Paediatric Influenza Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Europe Paediatric Influenza Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Europe Paediatric Influenza Treatment Market Share by Type (2019-2030)

Figure 28. Europe Paediatric Influenza Treatment Market Share by Application (2019-2030)

Figure 29. Europe Paediatric Influenza Treatment Market Share by Country (2019-2030)

Figure 30. Germany Paediatric Influenza Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. France Paediatric Influenza Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. U.K. Paediatric Influenza Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Italy Paediatric Influenza Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Russia Paediatric Influenza Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Nordic Countries Paediatric Influenza Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. China Paediatric Influenza Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. China Paediatric Influenza Treatment Market Share by Type (2019-2030)

Figure 38. China Paediatric Influenza Treatment Market Share by Application (2019-2030)

Figure 39. Asia Paediatric Influenza Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Asia Paediatric Influenza Treatment Market Share by Type (2019-2030)

Figure 41. Asia Paediatric Influenza Treatment Market Share by Application (2019-2030)

Figure 42. Asia Paediatric Influenza Treatment Market Share by Region (2019-2030)

Figure 43. Japan Paediatric Influenza Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. South Korea Paediatric Influenza Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. China Taiwan Paediatric Influenza Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Southeast Asia Paediatric Influenza Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. India Paediatric Influenza Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Australia Paediatric Influenza Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. Middle East, Africa, and Latin America Paediatric Influenza Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 50. Middle East, Africa, and Latin America Paediatric Influenza Treatment Market Share by Type (2019-2030)

Figure 51. Middle East, Africa, and Latin America Paediatric Influenza Treatment Market Share by Application (2019-2030)

Figure 52. Middle East, Africa, and Latin America Paediatric Influenza Treatment Market Share by Country (2019-2030)

Figure 53. Brazil Paediatric Influenza Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Mexico Paediatric Influenza Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. Turkey Paediatric Influenza Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. Saudi Arabia Paediatric Influenza Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 57. Israel Paediatric Influenza Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 58. GCC Countries Paediatric Influenza Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 59. GlaxoSmithKline Revenue Growth Rate in Paediatric Influenza Treatment Business (2019-2024)

Figure 60. NATCO Pharma Revenue Growth Rate in Paediatric Influenza Treatment Business (2019-2024)

Figure 61. NESHER PHARMS Revenue Growth Rate in Paediatric Influenza Treatment Business (2019-2024)

Figure 62. Roche Revenue Growth Rate in Paediatric Influenza Treatment Business (2019-2024)

Figure 63. Atabay Kimya Sanayi ve Ticaret Revenue Growth Rate in Paediatric Influenza Treatment Business (2019-2024)

Figure 64. Cipla Revenue Growth Rate in Paediatric Influenza Treatment Business (2019-2024)

Figure 65. Hetero Pharma Revenue Growth Rate in Paediatric Influenza Treatment Business (2019-2024)

Figure 66. Teva Pharmaceutical Revenue Growth Rate in Paediatric Influenza Treatment Business (2019-2024)

Figure 67. Olainfarm Revenue Growth Rate in Paediatric Influenza Treatment Business (2019-2024)

Figure 68. Bottom-up and Top-down Approaches for This Report

Figure 69. Data Triangulation

Figure 70. Key Executives Interviewed